399 related articles for article (PubMed ID: 28547134)
1. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.
Schmidt T; Mussawy H; Rolvien T; Hawellek T; Hubert J; Rüther W; Amling M; Barvencik F
Osteoporos Int; 2017 Sep; 28(9):2653-2662. PubMed ID: 28547134
[TBL] [Abstract][Full Text] [Related]
2. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.
Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR
J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187
[TBL] [Abstract][Full Text] [Related]
3. Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I
Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic.
Desborough R; Nicklin P; Gossiel F; Balasubramanian M; Walsh JS; Petryk A; Teynor M; Eastell R
Bone; 2021 Mar; 144():115795. PubMed ID: 33301960
[TBL] [Abstract][Full Text] [Related]
5. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
Genest F; Seefried L
Osteoporos Int; 2018 Aug; 29(8):1815-1825. PubMed ID: 29774402
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of hypophosphatasia diagnosed in adults.
Berkseth KE; Tebben PJ; Drake MT; Hefferan TE; Jewison DE; Wermers RA
Bone; 2013 May; 54(1):21-7. PubMed ID: 23352924
[TBL] [Abstract][Full Text] [Related]
7. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
Bone; 2018 May; 110():96-106. PubMed ID: 29360619
[TBL] [Abstract][Full Text] [Related]
10. Predictive modeling of hypophosphatasia based on a case series of adult patients with persistent hypophosphatasemia.
Garcia-Carretero R; Olid-Velilla M; Perez-Torrella D; Torres-Pacho N; Darnaude-Ortiz MT; Bustamate-Zuloeta AD; Tenorio JA
Osteoporos Int; 2021 Sep; 32(9):1815-1824. PubMed ID: 33619648
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of hypophosphatasia.
Gennero I; Conte-Auriol F; Salles JP
Arch Pediatr; 2017 May; 24(5S2):5S57-5S60. PubMed ID: 29405933
[TBL] [Abstract][Full Text] [Related]
12. ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.
Camacho PM; Mazhari AM; Wilczynski C; Kadanoff R; Mumm S; Whyte MP
Endocr Pract; 2016 Aug; 22(8):941-50. PubMed ID: 27042741
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum alkaline phosphatase and pyridoxal-5'-phosphate levels in hypophosphatasia.
Iqbal SJ; Brain A; Reynolds TM; Penny M; Holland S
Clin Sci (Lond); 1998 Feb; 94(2):203-6. PubMed ID: 9536930
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and fracture risk in adult patients with hypophosphatasia.
Genest F; Claußen L; Rak D; Seefried L
Osteoporos Int; 2021 Feb; 32(2):377-385. PubMed ID: 32879991
[TBL] [Abstract][Full Text] [Related]
15. Absence of recognition of low alkaline phosphatase level in a tertiary care hospital.
Maman E; Borderie D; Roux C; Briot K
Osteoporos Int; 2016 Mar; 27(3):1251-1254. PubMed ID: 26446772
[TBL] [Abstract][Full Text] [Related]
16. Musculoskeletal pain and muscular weakness as the main symptoms of adult hypophosphatasia in a Spanish cohort: clinical characterization and identification of a new ALPL gene variant.
Calmarza P; Lapresta C; Martínez García M; Ochoa J; Sienes Bailo P; Acha Pérez J; Beltrán Audera J; González-Roca E
J Bone Miner Metab; 2023 Sep; 41(5):654-665. PubMed ID: 37351650
[TBL] [Abstract][Full Text] [Related]
17. Urine phosphoethanolamine is a specific biomarker for hypophosphatasia in adults.
Shajani-Yi Z; Ayala-Lopez N; Black M; Dahir KM
Bone; 2022 Oct; 163():116504. PubMed ID: 35878747
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study.
Hepp N; Frederiksen AL; Duno M; Jørgensen NR; Jensen JB
Osteoporos Int; 2022 Dec; 33(12):2595-2605. PubMed ID: 35986118
[TBL] [Abstract][Full Text] [Related]
19. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults.
Riancho-Zarrabeitia L; García-Unzueta M; Tenorio JA; Gómez-Gerique JA; Ruiz Pérez VL; Heath KE; Lapunzina P; Riancho JA
Eur J Intern Med; 2016 Apr; 29():40-5. PubMed ID: 26783040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
